ResMed
NYSE:RMD Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 69 Fair Values set on narratives written by author
WA
Consensus Narrative from 14 Analysts
AirSense 11 Expansion And AI Investments Will Improve Patient Care Worldwide
Key Takeaways Expanding the AirSense 11 platform and launching innovative CPAP products could boost revenue and market share significantly worldwide. Strategic investments in AI and digital health platforms are expected to improve patient outcomes, operational efficiencies, and long-term earnings growth.
View narrativeUS$258.97
FV
10.5% undervalued intrinsic discount7.72%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative
23 days ago author updated this narrative